In a double transgenic heart failure mouse model expressing both Calsequestrin (Csq) and TNNI3K (TNNI3Ktg/Csqtg), TNNI3K was identified as a modifier of disease severity [3]. This evidence concerns the gene TNNI3K and heart failure.